Go Pro

Needham & Company LLC Reaffirms Buy Rating for Synopsys (NASDAQ:SNPS)

Synopsys logo with Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Needham reaffirmed its Buy rating on Synopsys and maintained a $580 price target, implying approximately 41% upside from the reported $410 share price. Analysts overall rate the stock a “Moderate Buy,” with a consensus target of $563.71.
  • Synopsys exceeded quarterly expectations, reporting $2.48 billion in revenue, up 42.4% year over year, and $3.91 in EPS versus the $3.67 consensus. Management also raised fiscal 2026 guidance, citing continued AI-driven demand for semiconductor design software.
  • Despite strong results and an improved outlook, the stock traded lower, partly because fourth-quarter revenue guidance came in slightly below consensus and the shares carry a high valuation of roughly 95 times earnings.
  • MarketBeat previews the top five stocks to own by September 1st.

Synopsys (NASDAQ:SNPS - Get Free Report)'s stock had its "buy" rating reiterated by research analysts at Needham & Company LLC in a research note issued on Thursday,Benzinga reports. They currently have a $580.00 price target on the semiconductor company's stock. Needham & Company LLC's target price would suggest a potential upside of 41.46% from the company's current price.

Several other equities research analysts also recently weighed in on SNPS. Zacks Research downgraded shares of Synopsys from a "strong-buy" rating to a "hold" rating in a research note on Friday, August 21st. Robert W. Baird set a $560.00 target price on Synopsys in a research report on Thursday. Weiss Ratings reaffirmed a "hold (c-)" rating on shares of Synopsys in a research note on Monday, June 8th. Rosenblatt Securities reissued a "buy" rating and issued a $575.00 price objective on shares of Synopsys in a research note on Tuesday. Finally, BNP Paribas Exane upped their target price on Synopsys from $425.00 to $450.00 and gave the stock an "underperform" rating in a research report on Thursday, May 28th. Eleven investment analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, Synopsys has an average rating of "Moderate Buy" and a consensus target price of $563.71.

Read Our Latest Stock Analysis on Synopsys

Synopsys Stock Performance

NASDAQ SNPS opened at $410.00 on Thursday. The company has a market capitalization of $78.51 billion, a price-to-earnings ratio of 94.91, a PEG ratio of 2.40 and a beta of 1.23. Synopsys has a twelve month low of $366.00 and a twelve month high of $615.79. The stock has a fifty day simple moving average of $416.71 and a 200 day simple moving average of $439.84. The company has a quick ratio of 1.32, a current ratio of 1.43 and a debt-to-equity ratio of 0.33.

Synopsys (NASDAQ:SNPS - Get Free Report) last posted its quarterly earnings data on Wednesday, August 26th. The semiconductor company reported $3.91 EPS for the quarter, topping analysts' consensus estimates of $3.67 by $0.24. The company had revenue of $2.48 billion for the quarter, compared to analyst estimates of $2.44 billion. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.The firm's quarterly revenue was up 42.4% on a year-over-year basis. During the same period in the previous year, the firm earned $3.39 earnings per share. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. Sell-side analysts expect that Synopsys will post 10.64 EPS for the current year.

Insider Activity at Synopsys

In related news, CFO Shelagh Glaser sold 3,394 shares of Synopsys stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $450.02, for a total value of $1,527,367.88. Following the sale, the chief financial officer owned 14,358 shares of the company's stock, valued at approximately $6,461,387.16. The trade was a 19.12% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of the company's stock in a transaction that occurred on Monday, June 15th. The shares were sold at an average price of $458.96, for a total value of $6,702,192.88. Following the completion of the transaction, the chief executive officer owned 75,020 shares in the company, valued at approximately $34,431,179.20. The trade was a 16.29% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Company insiders own 0.56% of the company's stock.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the company. Sankala Group LLC purchased a new stake in Synopsys during the fourth quarter valued at about $25,000. Elevation Wealth Partners LLC increased its stake in shares of Synopsys by 96.4% in the second quarter. Elevation Wealth Partners LLC now owns 55 shares of the semiconductor company's stock worth $25,000 after purchasing an additional 27 shares in the last quarter. Osbon Capital Management LLC purchased a new position in shares of Synopsys in the second quarter worth about $25,000. Caitong International Asset Management Co. Ltd bought a new stake in shares of Synopsys in the fourth quarter valued at approximately $28,000. Finally, IMG Wealth Management Inc. bought a new stake in shares of Synopsys in the second quarter valued at approximately $28,000. Hedge funds and other institutional investors own 85.47% of the company's stock.

Key Headlines Impacting Synopsys

Here are the key news stories impacting Synopsys this week:

  • Positive Sentiment: Synopsys reported fiscal Q3 revenue of $2.477 billion, up 42.4% year over year, while non-GAAP EPS of $3.91 exceeded the $3.67 consensus estimate. GAAP EPS was $2.84, compared with $1.51 a year earlier. Synopsys Posts Financial Results for Third Quarter Fiscal Year 2026
  • Positive Sentiment: Management raised fiscal 2026 guidance to approximately $9.715 billion in revenue and $15.07 in non-GAAP EPS at the midpoint. Fourth-quarter EPS guidance of $4.10-$4.16 also sits above the $3.78 consensus estimate, supporting confidence in continued demand. Synopsys raises annual forecasts on AI-driven chip design software demand
  • Positive Sentiment: Synopsys cited broad-based strength in Design Automation and sustained AI-related investment in semiconductor and infrastructure development. Its partnership with Nvidia, including Nvidia’s reported $2 billion investment, reinforces the long-term AI engineering opportunity. Nvidia’s $2 Billion Synopsys Bet Signals AI’s Next Frontier
  • Positive Sentiment: Rosenblatt Securities reaffirmed its Buy rating and maintained a $575 price target, implying substantial upside from the reference price. Rosenblatt Reiterates Buy Rating on Synopsys
  • Neutral Sentiment: The earnings call emphasized Synopsys’s shift toward autonomous engineering systems and significant customer productivity gains from AI, strengthening the long-term narrative but also raising investor expectations. Synopsys Q3 2026 Earnings Call Transcript
  • Negative Sentiment: Despite the earnings beat and raised outlook, SNPS traded lower after the release. Fourth-quarter revenue guidance of $2.53-$2.58 billion is slightly below the roughly $2.6 billion consensus, while the stock’s elevated valuation—near 95 times earnings—leaves limited room for execution concerns or merely incremental guidance improvements.

About Synopsys

(Get Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Featured Articles

Analyst Recommendations for Synopsys (NASDAQ:SNPS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Synopsys Right Now?

Before you consider Synopsys, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.

While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines